Glenview Capital Management - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 287 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.8%.

Quarter-by-quarter ownership
Glenview Capital Management ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q1 2022$18,770,000
-13.7%
158,301
+0.3%
0.38%
-18.1%
Q4 2021$21,751,000
+36.9%
157,835
+38.0%
0.46%
+61.1%
Q3 2021$15,884,000
-63.2%
114,345
-74.3%
0.29%
-59.7%
Q2 2021$43,172,000
+37.7%
444,701
-3.0%
0.71%
+34.5%
Q1 2021$31,345,000
+396.8%
458,600
+372.6%
0.53%
+168.2%
Q3 2020$6,309,000
-28.3%
97,047
-19.4%
0.20%
-18.5%
Q2 2020$8,797,000120,3320.24%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q4 2021
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 490,422$12,755,87613.24%
FNY Investment Advisers, LLC 30$00.00%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders